4//SEC Filing
Moscato Robert Jr. 4
Accession 0001493152-18-010074
CIK 0000737207other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 8:00 PM ET
Size
9.0 KB
Accession
0001493152-18-010074
Insider Transaction Report
Form 4
Moscato Robert Jr.
DirectorChief Executive Officer
Transactions
- Purchase
Warrants to Purchase Common Stock
2018-07-12+300,000→ 300,000 total(indirect: See footnote)Exercise: $0.55From: 2018-07-12→ common stock (300,000 underlying) - Purchase
Series F Convertible Preferred Stock
2018-07-12$5000.00/sh+40$200,000→ 40 total(indirect: See footnote)Exercise: $0.50From: 2018-07-12→ common stock (400,000 underlying)
Footnotes (3)
- [F1]Each outstanding share of Series F Preferred Stock shall be converted into common stock on the earliest to occur of: (i) any date more than 30 trading days after the closing of the issuer's private placement of shares of its Series F Preferred Stock and warrants to purchase shares of its common stock (the "Offering") that the closing price of the Issuer's common stock on each of the trading days immediately prior to such conversion exceeds $5.00; (ii) the three year anniversary of the closing of the Offering; and (iii) the date on which the holders of a majority of the outstanding shares of Series F Preferred Stock elect to convert all of the outstanding shares of Series F Preferred Stock.
- [F2]The reporting person is the majority member and manager of the general partner of the entity that holds the applicable securities. In such position, the reporting person has the power to control the voting and disposition of the applicable securities.
- [F3]The warrants expire on the five year anniversary of the closing of the Offering.
Documents
Issuer
Marina Biotech, Inc.
CIK 0000737207
Entity typeother
Related Parties
1- filerCIK 0001723420
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 8:00 PM ET
- Size
- 9.0 KB